BridgeMD
New treatment option for Sports Injuries
Official title THE MYOFASCIAL SYSTEM AND MINIMIZING THE RISK OS INJURY IN SPORT
ClinicalTrials.gov ID: NCT06895720
What this study is testing
- What it's testing
- The aim of the study is to evaluate the effect of myofascial self-release on muscle mechanical properties, performance, neuromuscular function, and injury risk reduction in young soccer players. The hypothesis is a reduction in the number of injuries in the experimental group, as well as improvements in muscle mechanical properties, performance, and neuromuscular function in young soccer players.The study will be a randomized clinical trial with a convenience sample of approximately 65 male athletes aged between 14 and 18 years, divided into control and experimental groups.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 18, men only
You may be able to join if
- Athletes at the youth and junior levels
- Registered with the respective football association
- Athletes with no history of injury in the past 3 months
You likely can't join if
- Athletes who failed pre-season medical examinations
- Athletes with a history of previous surgery or lower limb fractures in the last 5 years
- Athletes undergoing physiotherapy rehabilitation at the time of the study
- Athletes participating in another injury prevention program or specific training
The study team makes the final eligibility decision.
Where it's taking place
- Fão, Porto District, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 14 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fão, Porto District, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.